Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.2.3.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.568EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.568EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
P.1.13 (Gamma)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
P.1.13 (Gamma)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.372EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.372EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.634EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.634EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
C.37.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
C.37.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.8EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.49EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.17EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.42EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.42EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.10EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.4.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HK.19EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
HK.19EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GR.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GR.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.21EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.21EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.22.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.22.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FE.1.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FE.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBL.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBL.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.56EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.56EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.16.3EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.16.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.630EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.630EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.360EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.360EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.578EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used